a monoclonal antibody that is being studied in the treatment of some types of cancer. monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. volociximab binds to a protein that is found on cells that line some tumor blood vessels. it is a type of angiogenesis inhibitor. also called m200.
出典:Wiktionary
This etymology is incomplete. You can help Wiktionary by elaborating on the origins of this term.
volociximab (uncountable)
出典:Wikipedia
出典:『Wikipedia』 (2011/05/16 12:39 UTC 版)
Volociximab (also known as M200) is a chimeric monoclonal antibody jointly developed by PDL BioPharma and Biogen Idec for treatment of a variety of advanced solid tumors. It binds to and inhibits the functional activity of α5β1 integrin.